TransMedics (TMDX) EBITDA Margin (2018 - 2026)
TransMedics' EBITDA Margin came in at 17.89% for Q2 2026, down 9.63 percentage points from 27.51% a year earlier but up 3.42 percentage points from the prior quarter.
Powered by 
Analysis
TransMedics (TMDX) EBITDA Margin (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TransMedics reported EBITDA Margin of 17.66%, down 1.22 percentage points year-over-year; for FY2025, it was 22.42%, up 9.46 percentage points from FY2024.
- EBITDA Margin has increased in each of the last four years, with a five-year change of +119.09 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 12.97% in FY2024 (+21.47 pp), -8.50% in FY2023 (+21.41 pp), -29.92% in FY2022 (+94.37 pp) and -124.28% in FY2021 (-27.62 pp).
- The five-year range for quarterly EBITDA Margin is -208.20% (Q3 2021) to 27.51% (Q2 2025).
- Year-over-year, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +8.89 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q3 2022 (a gain of 190.09 percentage points), and the weakest in Q3 2021 (a drop of 155.42 percentage points).
- Business Quant data shows TMDX's EBITDA Margin at 14.47% (Q1 2026), 17.88% (Q4 2025) and 20.96% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 31.93% |
| 10 | TransMedics | 2.86 Bn | 975.91 Mn | 113.20 Mn | 17.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.89% |
| Mar 31, 2026 | 14.47% |
| Dec 31, 2025 | 17.88% |
| Sep 30, 2025 | 20.96% |
| Jun 30, 2025 | 27.51% |
| Mar 31, 2025 | 23.39% |
| Dec 31, 2024 | 11.78% |
| Sep 30, 2024 | 8.37% |
| Jun 30, 2024 | 14.97% |
| Mar 31, 2024 | 17.27% |
| Dec 31, 2023 | 7.65% |
| Sep 30, 2023 | -39.80% |
| Jun 30, 2023 | 0.90% |
| Mar 31, 2023 | -1.90% |
| Dec 31, 2022 | -17.51% |
| Sep 30, 2022 | -18.12% |
| Jun 30, 2022 | -43.61% |
| Mar 31, 2022 | -55.81% |
| Dec 31, 2021 | -127.12% |
| Sep 30, 2021 | -208.20% |
API Access
TransMedics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();